Yun De Hou

Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China.

Beijing Jindike Biotech Institute Ltd. was founded in 2001 and is based in Beijing, China. The Chinese company specializes in technology development, transfer of biomedicines, vaccines, and diagnostic agents. Additionally, they provide technical consultation services to medical centers.

Beijing Jindike Biotech Institute Ltd. was founded in 2001 and is based in Beijing, China. The Chinese company specializes in technology development, transfer of biomedicines, vaccines, and diagnostic agents. Additionally, they provide technical consultation services to medical centers.

Beijing Jindike Biotech Institute Ltd. was founded in 2001 and is based in Beijing, China. The Chinese company specializes in technology development, transfer of biomedicines, vaccines, and diagnostic agents. Additionally, they provide technical consultation services to medical centers.

Beijing Jindike Biotech Institute Ltd. was founded in 2001 and is based in Beijing, China. The Chinese company specializes in technology development, transfer of biomedicines, vaccines, and diagnostic agents. Additionally, they provide technical consultation services to medical centers.